XYNOMIC PHARMACEUTICALS HOLDINGS, INC. Common Stock, Convertible, Conversion Price, Decrease
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. reported Common Stock, Convertible, Conversion Price, Decrease of $10.15 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-06-01.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockConvertibleConversionPriceDecrease · last filed 2020-06-01
- XYNOMIC PHARMACEUTICALS HOLDINGS, INC. common stock, convertible, conversion price, decrease for fiscal 2019 was $10.15.
| Period end | Common Stock, Convertible, Conversion Price, Decrease 12 month |
|---|---|
| 2019-12-31 | $10.15 10-K · filed 2020-06-01 |